ProCE Banner Activity

Chronic Myeloid Leukemia Interactive Decision Support Tool: Expert Guidance on Monitoring Response to BCR-ABL1 Inhibitors in CML

Tool

Use this Interactive Decision Support Tool to compare your management of patients with CML with those of 5 renowned CML experts.

Released: March 30, 2022

Expiration: March 29, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Novartis Pharmaceuticals Corporation

Pfizer, Inc.

Additional Information

Program Medium

This program has been made available online.